Bacteriocins comprise a large and diverse family of antimicrobial toxins which has been identified in most microbial species of bacteria and Archaea. What unites them as a group is that they are all ribosomally synthesized bactericidal proteins. In addition, unlike most classical antibiotics, they are active against species that are closely related to the producing strains [1-5].
The abundance of bacteriocins has lead researchers to suggest that they play a critical role in mediating microbial interactions, community dynamics, and in maintaining microbial diversity. An additional role has recently been proposed for bacteriocins produced by Gram-positive bacteria, in which they mediate quorum sensing [1, 5, 6]. From an ecological point of view, bacteriocins are anticompetitor molecules that enable bacteria to respond to environmental challenges by reducing competition from sensitive bacterial strains that share the same ecological niche and have similar nutritional requirements [2, 6, 7].
As a family, bacteriocins are classified into two main groups: the toxins produced by Gram-positive and Gram-negative bacteria. Gram-positive bacteria produce bacteriocins which are selfregulated by specific transport mechanisms; a good example are the bacteriocins produced by lactic acid bacteria that are used in the preservation of meat and milk [5]. The toxins produced by Gram-negative bacteria are usually released through cell lysis and are dependent on the host regulatory pathways, like the SOS regulation; the most extensively studied example of this group are the colicins [1, 6, 8].
Colicins represent a heterogeneous group of antimicrobial, high molecular weight proteins [2, 6, 9, 10], which have a limited killing spectrum: they are toxic only to competing E. coli strains and Enterobacteriaceae, such as Salmonella and Citrobacter [5, 6, 11, 12]. The relative abundance of colicinogenic E. coli strains in natural and clinical isolates was shown to be about 15-50% [2, 13-15]. To date, 34 types of colicins have been identified [2, 10]; they were divided into two groups based on their encoding plasmid, their release system, and their mode of action: Group A is comprised of colicins that are encoded on small plasmids, are released into the medium through the lysis of the producing cell, and are translocated across the membrane through the Tol system. This group includes colicins A, E1 to E9, K, L, N, S4, U, and Y [6, 9, 16-18]. Group B includes colicins that are encoded on large plasmids, colicins whose secretion mechanism is not through lysis, and that require the TonB system for translocation. This group includes colicins B , D, Ia, Ib, M, 5, and 10 [6, 9, 10, 17]. However, some colicins might belong to one group and share homologies with colicins of the other group, which is the case of colicins D and 10 [1, 6].
Colicins are encoded on operons that carry at least two, usually three genes: the colicin structural gene that encodes the toxin (cxa), followed by the immunity gene (cxi), which encodes a protein that provides the producing cell with specific protection against its own toxin. The third gene is the lysis protein encoding gene (cxl), or the bacteriocin release protein that facilitates the release of colicin through lysis of the cytoplasmic membrane of the producing cell [1-3, 5, 9, 10] .
The colicin toxins have three linearly organized functional domains: the central part (R-domain) is the colicin receptor-binding domain that is involved in recognition of specific receptors on the target cell outer membrane, whereas the N-terminal portion (T-domain) is involved in translocation across the outer membrane; finally, the C-terminus (P-domain) contains both the specific toxic activity and a binding site to the immunity protein [2, 5, 6, 9, 10, 19, 20]
In general, colicin killing of sensitive bacteria follows three steps: (i) binding of a colicin molecule to a specific receptor, mostly to ones involved in nutrient uptake, located outside the target bacterial outer membrane; (ii) translocating through the cell envelope using either the Ton or Tol systems; and (iii) having gained access to the cell interior, the toxin kills the target cell by one of a variety of ways, including: pore formation in the cytoplasmic membrane, nonspecific degradation of cellular DNA by nuclease, inhibition of protein biosynthesis by the cleaving of 16s ribosomal RNA, or degradation of the bacterial cell wall resulting from inhibition of peptidoglycan synthesis [1, 2, 5, 9, 10].
Unlike bacteriocins produced by Gram-positive bacteria, the induction of the colicin gene clusters is controlled and regulated by the host cell’s pathways, mainly by the SOS system [1, 2, 6, 9]. Production of the toxins is induced under conditions of stress such as DNA-damage, increasing population density or nutrient depletion. Once the colicin is produced, it is released to the extracellular environment by the lysis protein, causing the host cell’s death [5, 18, 22]. However, only a small fraction (less than 3%) of colicinogenic cells of the population "commits suicide” [6, 11, 13, 15, 21, 22].
The SOS response has been studied extensively in E. coli; the SOS genes are normally repressed and the SOS genes’ expression is the interplay of the LexA and RecA proteins that function as repressor and activator, respectively. Under standard conditions, colicin synthesis is switched off in most cells of a bacterial population as the SOS system is repressed by the LexA protein by binding to a conserved sequence upstream the operon
. Under DNA damage, the LexA is derepressed by the activation of the RecA protein, which induces the cleavage of the LexA repressor, consequently provoking the induction of an ensemble of DNA repair proteins as well as the colicin encoding genes [2, 6, 10, 11, 13, 23-26].
So far, the regulation of only two colicins have been the subject of extensive study: Colicin E1 was found to be produced in response to a variety of assaults, including mutagenic agents, anaerobiosis, nutrient depletion and catabolite repression, suggesting that regulators other than SOS agents interfere with this colicin transcription [27, 28]. Colicin K [29], on the other hand, was found to be mainly induced by guanosine tetraphosphate (ppGpp), while the SOS response was found to be a mild signal for its expression. Amino acid starvation induced colicin K production [30, 31] while the expression invoked by DNA damage was not prominent. Interestingly, both colicin E1 and K belong to group A colicins; therefore, what is known so far about colicins has been obtained from seemingly similar proteins [30].
Previous studies have explored the role that SOS triggers play in colicin production, investigating the regulatory elements involved in their expression; the results showed that certain triggers such as, bile salts and β-lactams antibiotics induce the production of colicins though not through the promoter region located upstream to the initiation codon [32], suggesting that different mechanisms are involved in regulating colicin expression [33].
References
1. Riley, M.A. and J.E. Wertz, Bacteriocins: Evolution, ecology, and application. Annual Review of Microbiology, 2002. 56: p. 117-137.
2. Cursino, L., et al., Recent updated aspects of colicins of Enterobacteriaceae. Brazilian Journal of Microbiology, 2002. 33(3): p. 185-195.
3. Riley, M.A., Positive Selection for Colicin Diversity in Bacteria. Molecular Biology and Evolution, 1993. 10(5): p. 1048-1059.
4. de Souza, E.L., C.A. da Silva, and C.P. de Sousa, Bacteriocins: Molecules of fundamental impact on the microbial ecology and potential food biopreservatives. Brazilian Archives of Biology and Technology, 2005. 48(4): p. 559-566.
5. Njuguna, P., Studies on the Manipulation of Gastrointestinal Tract Bacteria, in Biological Sciences. 2005, University of Wollongong. p. 165.
6. Cascales, E., et al., Colicin biology. Microbiology and Molecular Biology Reviews, 2007. 71(1): p. 158-229.
7. Pagie, L. and P. Hogeweg, Colicin diversity: a result of eco-evolutionary dynamics. Journal of Theoretical Biology, 1999. 196(2): p. 251-+.
8. Riley, M.A. and J.E. Wertz, Bacteriocin diversity: ecological and evolutionary perspectives. Biochimie, 2002. 84(5-6): p. 357-364.
9. Hands, S.L., Biophysical investigations of the mechanism of colicin transloctaion in School of Pharmacy. 2004, University of Nottingham.
10. Smarda, J. and D. Smajs, Colicins - Exocellular lethal proteins of Escherichia coli. Folia Microbiologica, 1998. 43(6): p. 563-582.
11. Spangler, R., et al., Colicin Synthesis and Cell-Death. Journal of Bacteriology, 1985. 163(1): p. 167-173.
12. Dale, J.W., Molecular genetics of bacteria. 3rd ed. 1998, West Sussex: John Wileyy & Sons Ltd. 310.
13. Alonso, G., G. Vílchez, and V.R. Lemoine, How bacteria protect themselves against channel-forming colicins. INTERNATL MICROBIOL, 2000. 3: p. 81–88.
14. Smarda, J., D. Smajs, and S. Horynova, Incidence of lysogenic, colicinogenic and siderophore-producing strains among human non-pathogenic Escherichia coli. Folia Microbiologica, 2006. 51(5): p. 387-391.
15. Lancaster, L.E., W. Wintermeyer, and M.V. Rodnina, Colicins and their potential in cancer treatment. Blood Cells Molecules and Diseases, 2007. 38(1): p. 15-18.
16. Lazdunski, C.J., et al., Colicin import into Escherichia coli cells. Journal of Bacteriology, 1998. 180(19): p. 4993-5002.
17. Braun, V., S.I. Patzer, and K. Hantke, Ton-dependent colicins and microcins: modular design and evolution. Biochimie, 2002. 84(5-6): p. 365-80.
18. Hands, S.L., et al., Interactions of TolB with the translocation domain of colicin E9 require an extended TolB box. Journal of Bacteriology, 2005. 187(19): p. 6733-6741.
19. Buchanan, S.K., et al., Structure of colicin I receptor bound to the R-domain of colicin Ia: implications for protein import. Embo Journal, 2007. 26(10): p. 2594-2604.
20. Fridd, S.L., I. Gokce, and J.H. Lakey, High level expression of His-tagged colicin pore-forming domains and reflections on the sites for pore formation in the inner membrane. Biochimie, 2002. 84(5-6): p. 477-483.
21. Sze, C.C., L.M.D. Bernardo, and V. Shingler, Integration of global regulation of two aromatic-responsive sigma(54)-dependent systems: a common phenotype by different mechanisms. Journal of Bacteriology, 2002. 184(3): p. 760-770.
22. Mulec, J., et al., A cka-gfp transcriptional fusion reveals that the colicin K activity gene is induced in only 3 percent of the population. Journal of Bacteriology, 2003. 185(2): p. 654-659.
23. Janion, C., Some aspects of the SOS response system - A critical survey. Acta Biochimica Polonica, 2001. 48(3): p. 599-610.
24. Shcaechter, M., in The Desk Encyclopedia of Microbiology 2003: Granger. p. 927-930.
25. Perez-Capilla, T., et al., SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. Journal of Bacteriology, 2005. 187(4): p. 1515-1518.
26. Schuldiner, S., et al., Induction of SoS Functions by Alkaline Intracellular Ph in Escherichia-Coli. Journal of Bacteriology, 1986. 168(2): p. 936-939.
27. Dongling Zheng, C.C., Jon L. Hobman and Stephen D. Minchin, Identification of the CRP regulon using in vitro and in vivo transcriptional profiling. Nucleic Acids Research, 2004. 32(19): p. 5874–5893.
28. Salles, B., J.M. Weisemann, and G.M. Weinstock, Temporal control of colicin E1 induction. J Bacteriol, 1987. 169(11): p. 5028-34.
29. Tsao, S.S. and W.F. Goebell, Colicin K .8. Immunological Properties of Mitomycin-Induced Colicin K. Journal of Experimental Medicine, 1969. 130(6): p. 1313-&.
30. Kuhar, I. and D. Zgur-Bertok, Transcription regulation of the colicin K cka gene reveals induction of colicin synthesis by differential responses to environmental signals. Journal of Bacteriology, 1999. 181(23): p. 7373-7380.
31. Jishage, M., et al., Regulation of or factor competition by the alarmone ppGpp. Genes & Development, 2002. 16(10): p. 1260-1270.
32. Sharon-Gojman Revital, O.G., Regulation of Colicin Production by SOS Inducers. 2008, Ben Gurion University -Albert Katz International School for Desert Studies: Sde Boqer.
33. Gillor, O., J.A.C. Vriezen, and M.A. Riley, The role of SOS boxes in enteric bacteriocin regulation. Microbiology-Sgm, 2008. 154: p. 1783-1792.
34. Sharon-Gojman, R., Regulation of Colicin Production by SOS Inducers, in Department of Environmental Hydrology & Microbiology. 2008, Ben Gurion University of Negev: Sde Boqer.
35. Deegan, L.H., et al., Bacterlocins: Biological tools for bio-preservation and shelf-life extension. International Dairy Journal, 2006. 16(9): p. 1058-1071.
36. Diez-Gonzalez, F., Applications of bacteriocins in livestock. Curr Issues Intest Microbiol, 2007. 8(1): p. 15-23.
37. Trautner, B.W., R.A. Hull, and R.O. Darouiche, Colicins prevent colonization of urinary catheters. Journal of Antimicrobial Chemotherapy, 2005. 56(2): p. 413-415.
38. Hardy, K.G. and G.G. Meynell, Induction of Colicin Factor E2-P9 by Mitomycin-C. Journal of Bacteriology, 1972. 112(2): p. 1007-&.
39. Wei, Y., A.C. Vollmer, and R.A. LaRossa, In vivo titration of mitomycin C action by four Escherichia coli genomic regions on multicopy plasmids. Journal of Bacteriology, 2001. 183(7): p. 2259-2264.
40. Winson, M.K., et al., Engineering the luxCDABE genes from Photorhabdus luminescens to provide a bioluminescent reporter for constitutive and promoter probe plasmids and mini-Tn5 constructs. Fems Microbiology Letters, 1998. 163(2): p. 193-202.
41. Tina K. Van Dyk, R.A.R., Photorhabdus luminescens luXCDABE Promoter Probe Vectors, in Bioluminescence Methods and Protocols. 2008, Humana Press. p. 85-95.
42. Cascales, E., et al., Colicin Biology. Microbiology and Molecular Biology Reviews., 2007. 71(1): p. 158-229.
43. Herschma.Hr and D.R. Helinski, Comparative Study of Events Associated with Colicin Induction. Journal of Bacteriology, 1967. 94(3): p. 691-&.
44. Bernstein, C., et al., Bile salt activation of stress response promoters in Escherichia coli. Current Microbiology, 1999. 39(2): p. 68-72.
45. Braun, V., H. Pilsl, and P. Gross, Colicins - Structures, Modes of Action, Transfer through Membranes, and Evolution. Archives of Microbiology, 1994. 161(3): p. 199-206.
46. Little, J.W. and D.W. Mount, The Sos Regulatory System of Escherichia-Coli. Cell, 1982. 29(1): p. 11-22.
47. Lehtolainen, T., et al., In vitro antimicrobial susceptibility of Escherichia coli isolates from clinical bovine mastitis in Finland and Israel. Journal of Dairy Science, 2003. 86(12): p. 3927-3932.
48. Miller, C., et al., SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science, 2004. 305(5690): p. 1629-1631.
49. O'Reilly, E.K. and K.N. Kreuzer, Isolation of SOS constitutive mutants of Escherichia coli. Journal of Bacteriology, 2004. 186(21): p. 7149-7160.
50. A.A. Hossneara, M.S.R.K., M.J. Islam, K.H.M.N.H. Nazir and M.T. Rahman, Detection of colicinogenic Escherichia coli isolates and interrelatedness with their
enteropathogenicity and antibiotic resistant pattern. J. Bangladesh Soc. Agric. Sci. Technol, 2007. 4(1 & 2): p. 173-176.
51. Humayun, M.Z., SOS and Mayday: multiple inducible mutagenic pathways in Escherichia coli. Molecular Microbiology, 1998. 30(5): p. 905-910.
52. McLenigan, M., et al., Novel Escherichia coli umuD' mutants: Structure-function insights into SOS mutagenesis. Journal of Bacteriology, 1998. 180(17): p. 4658-4666.